Nvidia reported another quarter of blockbuster growth, but Wall Street barely blinked. The chipmaker's stock fell 2.3% even after it beat estimates on data-center demand and guided to roughly 75% revenue growth in fiscal 2028. The muted reaction is a sign that the so-called AI trade is now being priced less on near-term fundamentals and more on where interest rates are headed.
The pullback rippled through the semiconductor sector, dragging the iShares PHLX Semiconductor ETF—which holds about $43.7 billion in assets—down 1%. Meanwhile, UnitedHealth tumbled 9%, adding to the uneasy feel across US stocks and reminding investors that a single stock can still dominate an index's daily move.
Why good news isn't moving the market
For months, Nvidia has been the poster child of the AI boom, with its data-center chips powering everything from chatbots to cloud computing. When the company reports earnings, investors typically expect fireworks. But this time, even a beat and a rosy long-term outlook weren't enough to lift the shares.
That disconnect points to a broader shift in market psychology. With the Federal Reserve's next policy move still uncertain, traders are increasingly focused on how high borrowing costs might go. Higher interest rates tend to compress valuations for growth stocks, because future earnings are worth less in today's dollars. So even a company growing at 75% can see its stock stall if investors believe the Fed will keep rates elevated.
This dynamic is not unique to Nvidia. Across the tech sector, traders are bracing for the Fed minutes and a wave of economic data that could shape the central bank's next move. The minutes, due later this week, will offer a detailed look at the debate among policymakers at their last meeting.
UnitedHealth's slide adds to the gloom
While Nvidia's dip was modest, UnitedHealth's 9% drop was a jolt. The health insurance giant is one of the largest companies in the S&P 500, so its moves carry outsized weight on the index. The decline came without any obvious company-specific news in the brief, but it underscores how vulnerable the market is to single-stock shocks.
For everyday investors, this is a reminder that index funds can be swayed by a handful of big names. When a mega-cap like UnitedHealth stumbles, it can drag down the entire market, even if most other stocks are doing fine.
What it means for investors
The key takeaway is that earnings alone may not be enough to move stocks right now. With the Fed's rate path in focus, traders are pricing in a possible December hike, and that expectation is filtering into every asset class. A stronger dollar, for instance, has already weighed on copper prices and other commodities.
For those holding tech or growth stocks, the lesson is to watch the macro backdrop as much as individual company results. A company can beat expectations and still see its stock fall if the broader rate environment turns less favorable.
That said, Nvidia's long-term guidance suggests the AI boom is far from over. The company's projection of 75% revenue growth in fiscal 2028 implies that demand for its chips will remain robust for years. But in the near term, the market's mood may be dictated more by the Fed than by any single earnings report.
As the minutes arrive, investors will be parsing every word for clues about the central bank's next move. If the tone is hawkish, expect more pressure on growth stocks. If it's dovish, the AI trade could regain its footing. Either way, the days of ignoring interest rates are over.


